Cargando…
ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target
Lung adenocarcinoma is the most common histological type of lung cancer and is classified into adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA) and invasive adenocarcinoma (IA). Atypical adenomatous hyperplasia (AAH) lesions are possible precursors to adenocarcinoma. However, th...
Autores principales: | Kimura, Kenji, Matsumoto, Shinji, Harada, Takeshi, Morii, Eiichi, Nagatomo, Izumi, Shintani, Yasushi, Kikuchi, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060486/ https://www.ncbi.nlm.nih.gov/pubmed/31925985 http://dx.doi.org/10.1111/cas.14303 |
Ejemplares similares
-
Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma
por: Fujii, Shinsuke, et al.
Publicado: (2016) -
Podocalyxin influences malignant potential by controlling epithelial–mesenchymal transition in lung adenocarcinoma
por: Kusumoto, Hidenori, et al.
Publicado: (2017) -
Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion
por: Harada, Akikazu, et al.
Publicado: (2021) -
CKAP4 is a potential exosomal biomarker and therapeutic target for lung cancer
por: Nagoya, Akihiro, et al.
Publicado: (2023) -
Resection of a colloid adenocarcinoma of the lung: A case report
por: Kogita, Yuya, et al.
Publicado: (2023)